Chemours(CC)
Search documents
Chemours(CC) - 2024 Q4 - Annual Report
2025-02-18 11:14
Thermal & Specialized Solutions - The Thermal & Specialized Solutions segment is a leading global provider of refrigerants and thermal management solutions, with a focus on low GWP and sustainable technologies like Opteon™, which was commercialized in 2016[30] - In 2023, the company announced the initial commercialization of Opteon™ 2P50, targeted for the first half of 2026, to meet increasing demands for cooling capacities driven by advancements in AI and computing[31] - The company plans to expand Opteon™ YF capacity at its Corpus Christi, Texas facility by approximately 40% to meet customer needs transitioning to lower GWP refrigerants, with mechanical completion expected in Q4 2024[31] - The company has a leadership position in fluorine chemistry and materials science, competing against major players like Honeywell and Daikin in the Thermal & Specialized Solutions segment[32] - Chemours aims to achieve a goal of avoiding 325 million tons of carbon dioxide equivalent emissions globally by the end of 2025 through its low GWP products[86] Titanium Technologies - The Titanium Technologies segment has a nameplate capacity of approximately 1.1 million metric tons per year for TiO2 pigment, with production facilities in the U.S. and Mexico[40] - The Titanium Technologies Transformation Plan achieved approximately $190 million in cost savings, with $140 million related to 2024 and $50 million related to 2023, following the shutdown of the Kuan Yin facility in Taiwan[45] - The worldwide demand for TiO2 pigment in 2024 was estimated at approximately 7.3 million metric tons, with nameplate capacity at around 9.9 million metric tons[47] - The Titanium Technologies segment's raw materials include titanium-bearing ores, chlorine, and calcined petroleum coke, sourced from multiple suppliers to ensure supply chain flexibility[50] - In 2024, the top 10 customers in the Titanium Technologies segment represented about 41% of net sales, with one customer exceeding 10% of net sales[58] - TiO2 pigment sales volume is typically highest in the second and third quarters due to seasonality influenced by weather and holiday seasons[59] - The Titanium Technologies business focuses on sustainability with the Ti-Pure™ Sustainability product series, enhancing product sustainability designations[90] - Energy costs account for approximately 10% of the production cost in TiO2 pigment manufacturing, with access to low-cost natural gas in U.S. and Mexico facilities[54] Advanced Performance Materials - The Advanced Performance Materials segment serves around 1,000 customers globally, with no single customer accounting for more than 10% of net sales in 2024[71] - The Advanced Performance Materials segment is positioned for growth driven by demand for clean energy and advanced electronics technologies[64] - Chemours launched operations at THE Mobility F.C. Membranes Company in 2023 to enhance fuel cell and humidifier membrane manufacturing capacity[62] Environmental Commitment - Chemours aims for a 60% absolute reduction in greenhouse gas emissions by 2030 and a 25% reduction in Scope 3 emissions per ton of product by 2030[84] - The company has successfully reduced Scope 1 and Scope 2 GHG emissions by 60% and achieved a 99% reduction in air and water process emissions of fluorinated organic chemicals[87] - The company is subject to significant compliance costs related to environmental laws and regulations, which may increase over time[92] - The board of directors established an Environmental, Health, Safety, and Operations Performance committee to oversee environmental and safety risk management[102] Employee and Workforce Management - Chemours has approximately 6,000 employees globally, with 77% located in the Americas, 16% in Europe, and 7% in Asia Pacific[96] - The company reported a voluntary attrition percentage of approximately 8% for the year ended December 31, 2024, indicating effective employee retention strategies[108] - Chemours is committed to transparency in pay practices, having implemented measures to ensure equitable remuneration across its workforce[107] Financial Management and Risk - Chemours utilizes derivative financial instruments to manage risks associated with foreign currency exchange rates and commodity prices[498] - As of December 31, 2024, the company had 11 foreign currency forward contracts with a gross notional U.S. dollar equivalent of $196 million, resulting in a fair value of less than $1 million[501] - The company recognized a net gain of $5 million in 2024 from non-designated foreign currency forward contracts, compared to a net loss of $7 million in 2023[501] - Under the cash flow hedge program, the company had 173 foreign currency forward contracts with a notional U.S. dollar equivalent of $178 million and a fair value of $7 million as of December 31, 2024[502] - The company reported a pre-tax gain of $7 million in 2024 from cash flow hedges, compared to a pre-tax loss of $2 million in 2023[502] - The company designated euro-denominated debt as a hedge, recognizing a pre-tax gain of $47 million in 2024, following a pre-tax loss of $27 million in 2023[503] - The company entered into a cross-currency swap to convert $600 million of senior unsecured notes into €567 million, with a fair value of $5 million as of December 31, 2024[504] - The company had two interest rate swaps with a notional U.S. dollar equivalent of $300 million, resulting in a fair value of negative $3 million as of December 31, 2024[506] - A pre-tax gain of $9 million was recognized in 2024 from interest rate swaps, compared to a pre-tax loss of $6 million in 2023[506] - As of December 31, 2024, one customer represented approximately 7% of total accounts and notes receivable, indicating a diversified customer base[507] - The company did not have any commodity derivative financial instruments in place as of December 31, 2024 and 2023, indicating a strategy to manage commodity price risks through sales contracts[509]
Earnings Preview: Chemours (CC) Q4 Earnings Expected to Decline
ZACKS· 2025-02-11 16:06
Chemours (CC) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on February 18, 2025, might help the stock move higher if these key numbers are better than expe ...
Chemours, Tronox And Westlake Will See Earnings Rebound In Chemical Sector Amid TiO2 Recovery And Margin Expansion: Analyst
Benzinga· 2025-01-28 18:30
Group 1: Chemours Company (CC) - Analyst Peter Osterland initiated coverage with a Buy rating and a price forecast of $27, expecting strong earnings growth in 2025-2026 [1] - Margin expansion is anticipated in the Opteon refrigerant franchise, with a potential rebound in the TiO2 segment, where consensus estimates are seen as overly conservative [1] - Estimated EBITDA for 2024 is $775 million, for 2025 is $1.004 billion (+8% vs. Street), and for 2026 is $1.188 billion (+11% vs. Street) [2] Group 2: Tronox Holdings plc (TROX) - Coverage was initiated with a Buy rating and a price forecast of $17, with the company viewed as a strong player in the TiO2 industry due to its scale and vertical integration [3] - Improving TiO2 market fundamentals and potential anti-dumping duties on Chinese exports are expected to drive above-market volume growth and earnings upside [4] - Estimated EBITDA for 2024 is $563 million, for 2025 is $694 million (+6% vs. Street), and for 2026 is $802 million (+6% vs. Street) [4] Group 3: Minerals Technologies Inc. (MTX) - Coverage was initiated with a Buy rating and a price forecast of $103, highlighting the company's unique mineral reserves and engineering expertise as competitive advantages [5] - Sustainable mid-single-digit revenue growth is expected, with modest upside to consensus estimates for 2025-2026 [6] - Estimated EBITDA for 2024 is $404 million, for 2025 is $440 million (+3% vs. Street), and for 2026 is $471 million (+4% vs. Street) [6] Group 4: Westlake Corporation (WLK) - Analyst initiated coverage with a Buy rating and a price forecast of $168, noting the company's position as a vertically integrated market leader [7] - A strong cash balance of approximately $3 billion provides flexibility for further expansion through M&A or increased shareholder returns [7] - Estimated EBITDA for 2024 is $2.377 billion, for 2025 is $2.677 billion (+5% vs. Street), and for 2026 is $2.996 billion (+5% vs. Street) [8]
Chemours and PCC Group Enter Into Chlorine Supply Agreement
ZACKS· 2024-12-12 12:05
The Chemours Company (CC) recently announced that the PCC Group intends to build and operate a chlor-alkali facility on the grounds of Chemours' titanium dioxide (TiO2) plant in DeLisle, MS. Chemours and PCC have signed a chlorine supply agreement subject to certain customary conditions. The new plant will use cutting-edge technology to maximize energy efficiency and will have an annual nameplate capacity of 340,000 metric tons once operational. PCC will sell the co-product and caustic soda to key partners ...
Chemours (CC) Up 8.8% Since Last Earnings Report: Can It Continue?
ZACKS· 2024-12-04 17:37
A month has gone by since the last earnings report for Chemours (CC) . Shares have added about 8.8% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Chemours due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Chemours' Earnings and Revenues Surpass Estimates in Q3Chem ...
Chemours: Hasn't Been A Great Year, But The Long-Term Prospects Look Bright
Seeking Alpha· 2024-11-21 15:01
The Chemours Company (NYSE: CC ), a global performance chemical manufacturer, with strong clout in titanium dioxide (TiO 2) pigments (mainly used to facilitate whiteness and opacity across various applications), has proven to be a source of massive wealthAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not ...
Chemours' Earnings and Revenues Surpass Estimates in Q3
ZACKS· 2024-11-06 21:00
Key TakeawaysThe Chemours Company reported earnings of 40 cents a share, beating estimates of 32 cents.Shares of CC are down nearly 20% this past year, compared to the total chemical industry’s 8.3% rise.Register now to see our 7 Best Stocks for the Next 30 Days report – free today!The Chemours Company (CC) recorded a loss of $27 million or 18 cents per share in third-quarter 2024. This compares to a profit of $12 million or 8 cents in the year-ago quarter. Barring one-time items, earnings came in at 40 cen ...
Chemours(CC) - 2024 Q3 - Earnings Call Transcript
2024-11-04 16:25
Financial Data and Key Metrics Changes - Consolidated net sales for Q3 2024 were approximately $1.5 billion, up 1% year-over-year, driven by a 5% increase in volume, partially offset by a 3% decline in pricing [10][11] - Adjusted EBITDA decreased slightly from $211 million in the previous year to $208 million this quarter, primarily due to lower pricing [11] - The company reported a net loss of $27 million or $0.18 per diluted share compared to net income of $12 million or $0.08 per share in the prior year [13][14] Business Segment Performance - TSS achieved record net sales of approximately $460 million, a 6% increase from the prior year, driven by an 8% rise in volume [15] - TT's net sales fell 2% year-over-year to $679 million, primarily due to a 2% reduction in pricing, while adjusted EBITDA increased 23% to $85 million [17] - APM reported net sales of $348 million, a 1% increase compared to the prior year, driven by a 9% rise in volume, but adjusted EBITDA decreased 43% to $39 million [18] Market Data and Key Metrics Changes - The TSS business saw a robust 21% year-over-year increase in Opteon Refrigerants, which accounted for nearly 60% of total TSS refrigerant sales for the quarter [7] - The TT segment's adjusted EBITDA margin improved by 3 percentage points to 13% due to cost savings from the TT Transformation Plan [17] - APM's adjusted EBITDA margin fell 9 percentage points to 11%, primarily driven by cost mix combined with lower absorption [18] Company Strategy and Industry Competition - The company outlined a refreshed corporate strategy called "Pathway to Thrive," focusing on operational excellence, enabling growth, portfolio management, and strengthening the long term [36] - The strategy aims for a greater than 5% revenue CAGR from 2024 through 2027, targeting high-growth markets such as data center cooling and semiconductor fabrication [38] - The company plans to delay investments in the hydrogen market due to near-term weakness, while continuing to focus on high-return, low-risk initiatives [39][40] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in meeting customer demand due to stability in the macro environment and strong operational execution [6] - For Q4, TSS is expected to experience a sequential decline in net sales in the low teens, while continued double-digit growth in Opteon Refrigerants is anticipated [24] - The company expects adjusted EBITDA margins to remain around 30% or greater, assuming stable Freon pricing [27] Other Important Information - The company reported consolidated gross debt of $4.1 billion with approximately $1.2 billion in liquidity as of September 30, 2024 [20] - The company has made substantial progress on control issues, successfully remediating two of four material weaknesses as of Q3 [23] Q&A Session Summary Question: How long will higher levels of inventories of HFCs last and what pricing drag is expected moving into '25? - Management indicated that current HFC pricing levels are expected to persist into '25 due to inventory dynamics [49][50] Question: How do you see utilization rates evolving in TT moving into '25? - Management noted that while there is no significant market recovery, interest rate reductions could positively impact demand [51][52] Question: What are the expectations for TSS margins in 2025? - Management expects margins to remain above 30%, with various factors influencing pricing and costs [55][56] Question: What prompted the timing of the APM goodwill impairment? - The impairment was triggered by a strategic review of investments, particularly in the hydrogen market, which showed delayed future cash flows [60][61] Question: How does the company view the role of the TT business in the portfolio? - Management believes that the TT business remains valuable due to its cash generation capabilities and synergies with other segments [63][64] Question: What is the outlook for Freon pricing and demand? - Management noted that Freon prices are expected to remain low, influenced by inventory levels and regulatory transitions [66][71] Question: How has the corporate strategy shifted priorities compared to the last three years? - Management emphasized a disciplined approach to capital allocation, focusing on high-return investments while managing legacy liabilities [75]
Chemours(CC) - 2024 Q3 - Earnings Call Presentation
2024-11-04 15:28
Third Quarter 2024 Earnings Presentation November 4, 2024 Safe Harbor Statement and Other Matters 2 This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The wor ...
Chemours (CC) Q3 Earnings and Revenues Top Estimates
ZACKS· 2024-11-04 13:16
分组1 - Chemours reported quarterly earnings of $0.40 per share, exceeding the Zacks Consensus Estimate of $0.32 per share, but down from $0.64 per share a year ago, representing a 25% earnings surprise [1] - The company posted revenues of $1.5 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 5.32% and slightly up from $1.49 billion year-over-year [2] - Chemours has surpassed consensus EPS estimates three times over the last four quarters and topped consensus revenue estimates two times in the same period [2] 分组2 - The stock has underperformed, losing about 43.5% since the beginning of the year compared to the S&P 500's gain of 20.1% [3] - The current consensus EPS estimate for the coming quarter is $0.30 on revenues of $1.35 billion, and for the current fiscal year, it is $1.32 on revenues of $5.7 billion [7] - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 20% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]